OTCMKTS:MCUJF Medicure (MCUJF) Stock Price, News & Analysis → Biden replacement revealed? (From Paradigm Press) (Ad) Free MCUJF Stock Alerts $0.74 0.00 (0.00%) (As of 05/1/2024 ET) Add Compare Share Share Today's Range$0.74▼$0.7450-Day Range$0.68▼$0.9552-Week Range$0.68▼$1.26VolumeN/AAverage Volume2,534 shsMarket Capitalization$7.73 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get Medicure alerts: Email Address Ad InvestorPlaceHave You Seen Elon’s New A.I. Device? (Picture Inside)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...This strange new device to protect us against that A.I. threat... About Medicure Stock (OTCMKTS:MCUJF)Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.Read More MCUJF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MCUJF Stock News HeadlinesDecember 5, 2023 | finance.yahoo.comMedicure Announces New Partnership Through Its Marley Drug Subsidiary to Provide Brenzavvy(R) as an Affordable Medication for Americans with Type 2 DiabetesNovember 24, 2023 | msn.comMedicure approved to enrol patients in paediatric disease trialMay 1, 2024 | Crypto Swap Profits (Ad)He Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.November 23, 2023 | benzinga.comMedicure Announces FDA Provides Complete Approval to Enroll Patients in Its Pivotal Phase 3 Trial for Treatment of Rare Pediatric DiseaseNovember 21, 2023 | msn.comMedicure GAAP EPS of C$0.01, revenue of C$5MNovember 21, 2023 | finance.yahoo.comMedicure Reports Financial Results for Quarter Ended September 30, 2023October 24, 2023 | finance.yahoo.comMedicure Inc.'s (CVE:MPH) Stock Is Going Strong: Have Financials A Role To Play?October 2, 2023 | theglobeandmail.comMedicure: Top 10 Undervalued Drug Manufacturers Industry Stocks (MPH)May 1, 2024 | Crypto Swap Profits (Ad)He Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.August 25, 2023 | theglobeandmail.comClosing Bell: Medicure Inc flat on Thursday (MPH)August 15, 2023 | theglobeandmail.comClosing Bell: Medicure Inc flat on Monday (MPH)July 29, 2023 | theglobeandmail.comClosing Bell: Medicure Inc flat on Friday (MPH)July 29, 2023 | finance.yahoo.comMedicure Reports Financial Results For Quarter Ended June 30, 2023July 24, 2023 | finance.yahoo.comMedicure to Present Financial Results on July 31, 2023 Call at 8:30 AM ET for Quarter Ended June 30, 2023May 26, 2023 | finance.yahoo.comMedicure Reports Financial Results for Quarter Ended March 31, 2023May 24, 2023 | theglobeandmail.comClosing Bell: Medicure Inc down on Tuesday (MPH)May 21, 2023 | finance.yahoo.comPoly Medicure Limited (POLYMED.NS)May 5, 2023 | theglobeandmail.comClosing Bell: Medicure Inc up on Friday (MPH)April 6, 2023 | finance.yahoo.comMedicure Reports Financial Results for Quarter and Year Ended December 31, 2022April 5, 2023 | finance.yahoo.comMedicure To Present Financial Results on April 10, 2023 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2022February 1, 2023 | finance.yahoo.comMEDICURE ANNOUNCES RESIGNATION OF BOARD MEMBER AND GRANT OF STOCK OPTIONSNovember 25, 2022 | seekingalpha.comMedicure Inc. (MCUJF) Q3 2022 Earnings Call TranscriptNovember 24, 2022 | finance.yahoo.comMEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2022November 18, 2022 | finance.yahoo.comMEDICURE TO PRESENT FINANCIAL RESULTS ON NOVEMBER 25, 2022 CALL at 8:30 AM ET FOR QUARTER ENDED SEPTEMBER 30, 2022October 19, 2022 | investing.comPoly Medicure Ltd (PLMD)September 26, 2022 | finance.yahoo.comEARLY WARNING NEWS RELEASE - DR. ALBERT D. FRIESEN'S HOLDINGS IN MEDICURE INC.August 25, 2022 | seekingalpha.comMedicure Inc. (MCUJF) Q2 2022 Earnings Call TranscriptSee More Headlines Receive MCUJF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/08/2024Today5/01/2024Next Earnings (Estimated)5/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:MCUJF CUSIPN/A CIK1133519 Webwww.medicure.com Phone(204) 487-7412Fax204-488-9823EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-680,000.00 Net Margins-4.17% Pretax Margin-4.13% Return on Equity-4.29% Return on Assets-3.14% Debt Debt-to-Equity Ratio0.01 Current Ratio1.92 Quick Ratio1.55 Sales & Book Value Annual Sales$16.07 million Price / Sales0.48 Cash Flow$0.09 per share Price / Cash Flow8.35 Book Value$1.41 per share Price / Book0.52Miscellaneous Outstanding Shares10,440,000Free Float9,090,000Market Cap$7.73 million OptionableNot Optionable Beta0.92 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesDr. Neil Owens Ph.D.President & COODr. Reuben Saba Ph.D.Vice President of Scientific & Medical AffairsDr. Albert David Friesen Ph.D. (Age 77)Founder, CEO & Chairman of the board Comp: $173.31kMr. Haaris Uddin B.Com.CPA, Chief Financial OfficerKey CompetitorsChemomab TherapeuticsNASDAQ:CMMBImmune TherapeuticsOTCMKTS:IMUNeFFECTOR TherapeuticsNASDAQ:EFTRCyclerion TherapeuticsNASDAQ:CYCNBionomicsNASDAQ:BNOXView All Competitors MCUJF Stock Analysis - Frequently Asked Questions How have MCUJF shares performed in 2024? Medicure's stock was trading at $0.7754 at the beginning of 2024. Since then, MCUJF shares have decreased by 4.6% and is now trading at $0.74. View the best growth stocks for 2024 here. When is Medicure's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, May 24th 2024. View our MCUJF earnings forecast. How were Medicure's earnings last quarter? Medicure Inc. (OTCMKTS:MCUJF) released its earnings results on Monday, April, 8th. The company reported ($0.10) earnings per share (EPS) for the quarter. The firm had revenue of $3.73 million for the quarter. Medicure had a negative trailing twelve-month return on equity of 4.29% and a negative net margin of 4.17%. How do I buy shares of Medicure? Shares of MCUJF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MCUJF) was last updated on 5/1/2024 by MarketBeat.com Staff From Our Partners😱 This phenomenon is smashing regular market gainsMillPubHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceYour bank is lying to you.MyBankTrackerThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicure Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
